A Master of Science (MS) in Clinical Experimental and Therapeutics (CXPT) will be granted on the basis of completion of 28 total units. Students on the thesis track can earn at least 24 units through formal coursework and complete 4 units from work on a thesis, based on the results of an original investigation. There is a non-thesis option which entails completing all 28 units from formal coursework. Students on the non-thesis track may choose to perform an independent study resulting in a comprehensive review paper on the topic selected in agreement with their advisor. Students should choose either thesis or non-thesis option by the end of the first year of study and prior to the beginning of the second year.
The core course work includes the following recommended courses: CXPT 609 (4 units), CXPT 610 (4 units), CXPT 664 (3 units; for non-clinically trained students) and one course chosen between PM 510L (4 units) and CXPT 501 (4 units). The remaining elective units will be completed from courses offered within the Alfred Mann School of Pharmacy and Pharmaceutical Sciences or in related disciplines outside the school, approved by the Program Director. At least 75% of the 28 units must be at 500 level or above. One course with maximum of 4 units of upper division 400 level course may be applied toward the degree. Students, choosing the Master thesis option, should register for CXPT 594a (2 units) and CXPT 594b (2 units). Students choosing the independent project on the non-thesis track, can register for CXPT 590 course (2 units).
Additionally, 24 units will be sufficient to complete MS in CXPT degree for the students on the Progressive Degree (PD) track. All 24 units should be taken at 500 or higher level. PD students can also choose between the thesis or non-thesis options. Students choosing the non-thesis option should complete all 24 units from coursework.
You must be logged in to post a comment.